|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
JPS61122292A
(ja)
|
1984-11-16 |
1986-06-10 |
Teijin Ltd |
新規カルバサイクリン中間体の製法
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
DE3631229A1
(de)
|
1986-09-13 |
1988-03-24 |
Basf Ag |
Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
|
|
US4975369A
(en)
|
1988-04-21 |
1990-12-04 |
Eli Lilly And Company |
Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2736076A1
(en)
|
1991-03-18 |
1992-09-19 |
New York University |
Monoclonal and chimeric antibodies specific for human tumor necrosis factor
|
|
ATE255131T1
(de)
|
1991-06-14 |
2003-12-15 |
Genentech Inc |
Humanisierter heregulin antikörper
|
|
EP0614984B2
(en)
|
1993-03-05 |
2010-11-03 |
Bayer HealthCare LLC |
Anti-TNF alpha human monoclonal antibodies
|
|
US20060078564A1
(en)
*
|
2002-05-08 |
2006-04-13 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
|
|
US6384203B1
(en)
|
1999-05-12 |
2002-05-07 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
|
|
US6448035B1
(en)
|
1997-04-24 |
2002-09-10 |
Immunex Corporation |
Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
|
|
IL127127A0
(en)
*
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
|
CA2398251A1
(en)
|
2000-01-25 |
2001-08-02 |
Hyseq, Inc. |
Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
|
|
AU2001239955A1
(en)
|
2000-02-28 |
2001-09-12 |
Hyseq, Inc. |
Novel macrophage nucleic acids and polypeptides
|
|
EP1320599A2
(en)
|
2000-06-28 |
2003-06-25 |
Genetics Institute, LLC |
Pd-l2 molecules: pd-1 ligands and uses therefor
|
|
US7117096B2
(en)
*
|
2001-04-17 |
2006-10-03 |
Abmaxis, Inc. |
Structure-based selection and affinity maturation of antibody library
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
JP2005532256A
(ja)
*
|
2001-11-14 |
2005-10-27 |
イミユネツクス・コーポレイシヨン |
慢性関節リウマチを治療するためのｌｉｒ機能の調節
|
|
WO2003051834A2
(en)
|
2001-12-14 |
2003-06-26 |
President And Fellows Of Harvard College |
Immunocellular receptors related to neurological disorders
|
|
KR101351122B1
(ko)
|
2003-05-09 |
2014-01-14 |
듀크 유니버시티 |
Ｃｄ２０-특이적 항체 및 이를 이용한 방법
|
|
EP1915394B1
(en)
*
|
2005-05-20 |
2021-01-27 |
Lonza Biologics plc. |
High-level expression of recombinant antibody in a mammalian host cell
|
|
CN102875681A
(zh)
|
2005-07-08 |
2013-01-16 |
拜奥根Idec马萨诸塞公司 |
抗-αvβ6抗体及其用途
|
|
AU2006267090B2
(en)
|
2005-07-11 |
2013-03-07 |
Provention Bio, Inc. |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
|
|
EP1777523A1
(en)
|
2005-10-19 |
2007-04-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
|
|
AU2007212683A1
(en)
*
|
2006-01-23 |
2007-08-16 |
President And Fellows Of Harvard College |
Compositions and methods for enhancing neuronal plasticity and regeneration
|
|
CL2007000851A1
(es)
*
|
2006-03-30 |
2008-03-14 |
Novartis Ag |
Anticuerpo anti receptor del factor de crecimiento del hepatocito (c-met); adn que codifican cadenas livianas y pesadas del anticuerpo; composicion farmaceutica y kit que comprenden dicho anticuerpo; metodo para tratar trastorno relacionado con c-met
|
|
MX2008015771A
(es)
|
2006-06-14 |
2009-01-27 |
Macrogenics Inc |
Metodos para el tratamiento de padecimientos autoinmunes usando anticuerpos monoclonales con toxicidad reducida.
|
|
AU2007345745C1
(en)
|
2006-06-19 |
2013-05-23 |
Merck Sharp & Dohme Corp. |
ILT3 binding molecules and uses therefor
|
|
RU2447449C2
(ru)
|
2006-11-14 |
2012-04-10 |
Дженентек, Инк. |
Модуляторы нейрональной регенерации
|
|
US8536310B2
(en)
|
2007-10-17 |
2013-09-17 |
Arca Biopharma, Inc. |
Antibodies to CLL-1
|
|
US8715941B2
(en)
|
2007-11-16 |
2014-05-06 |
Arca Biopharma, Inc. |
Antibodies to LRP6
|
|
WO2009076359A2
(en)
*
|
2007-12-11 |
2009-06-18 |
Genentech, Inc. |
Modulators of neuronal regeneration
|
|
US20090285803A1
(en)
|
2008-05-13 |
2009-11-19 |
Jasvinder Atwal |
ANTI-PirB ANTIBODIES
|
|
PE20091969A1
(es)
|
2008-05-13 |
2010-01-15 |
Genentech Inc |
ANTICUERPOS ANTI-PirB
|
|
EP2460827A1
(en)
|
2008-06-30 |
2012-06-06 |
The Trustees Of The University Of Pennsylvania |
Fusion proteins comprising Fn14 and an inhibitory protein
|
|
US9221895B2
(en)
|
2009-03-13 |
2015-12-29 |
The Trustees Of The University Of Pennsylvania |
OX40/TRAIL fusion proteins
|
|
BR112012004777A2
(pt)
|
2009-09-03 |
2019-09-24 |
Genentech Inc |
métodos para tratar diagnósticar e monitorar artrite reumatoide
|
|
EP2525822B1
(en)
|
2010-01-20 |
2017-05-10 |
Merck Sharp & Dohme Corp. |
Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments
|
|
US8609095B2
(en)
*
|
2010-03-04 |
2013-12-17 |
Symphogen A/S |
Anti-HER2 antibodies and compositions
|
|
WO2012061620A1
(en)
|
2010-11-04 |
2012-05-10 |
Genentech, Inc. |
Methods for treating, diagnosing, and monitoring rheumatoid arthritis
|
|
AR086287A1
(es)
|
2011-05-05 |
2013-12-04 |
Baylor Res Inst |
Composicion inmunoestimulante, metodo
|
|
US20150174203A1
(en)
|
2012-05-30 |
2015-06-25 |
Icahn School Of Medicine At Mount Sinai |
Compositions And Methods For Modulating Pro-Inflammatory Immune Response
|